Learning Objectives

After viewing this presentation, the participant should be able to:

• Review guidelines regarding fertility preservation
• Assess the effect of treatments on ovarian reserve
• Discuss current fertility preservation options
• Evaluate success rates for:
  – Oocyte cryopreservation
  – Embryo cryopreservation
  – Ovarian tissue cryopreservation
• Describe novel protocols for random start stimulations

 top 
 

Target Audience

This activity is intended for the education of nurses and nurse practitioners specializing in reproductive medicine and assisted reproductive technologies.

 top 

Requirements for Successful Completion

To successfully complete this activity for CE credit, the participant will:
1. Take the pretest
2. Review the content in the presentation
3. Complete the posttest with a score of at least 3 correct answers
4. Fill out a brief evaluation

Upon completion of the requirements 1-4, a CE certificate will be available for download.

Release & Expiration Dates
November 1, 2019 to October 31, 2020

 top 

Disclosure Information and Off-Label Uses
It is the policy of Letters & Sciences to ensure balance, independence, objectivity, and scientific rigor in all their sponsored educational activities. All faculty members participating in this activity are expected to disclose to the participants any real or perceived conflicts of interest related to the content of their presentations.

It is not assumed that these relationships or financial interests will have an adverse impact on the faculty presentations. They simply are noted here to fully inform course participants.

Elizabeth S. Ginsburg, MD

• Has received research grant support from EMD Serono
• Has received consulting fees from Up-to-Date, Sanders and Parks
• Has agreed to disclose any unlabeled/unapproved uses of drugs or products referenced her presentation

William H. Kutteh, MD, PhD, HCLD

• Has received research grant support from Ferring Pharmaceuticals
• Has served on Speakers Bureau for AbbVie, Natera
• Will not be discussing or referring to unlabeled/unapproved uses of drugs, devices, products, protocols, or therapeutic strategies

Glenn L. Schattman, MD

• Has no relationships to disclose
• Has agreed to disclose any unlabeled/unapproved uses of drugs or products referenced his presentation

Daniel B. Shapiro, MD

• Has served as a consultant for Merck
• Owns stock in Prelude Fertility Holdings and Inception
• Will be discussing off-label uses of GnRH agonists in IVF

Executive Committee, CNE Committee, Planning Committee, Curriculum Committee Members
Letters & Sciences, the content managers/ members of the planning, executive and curriculum committees, report no relationships with commercial interests.

External Review
In accordance with the policies of Letters & Sciences, and in compliance with the standards of ANCC to identify and resolve any potential conflicts of interest, to assure fair balance, independence and objectivity, and to instill scientific rigor in all accredited activities, all presentations with any potential for conflict of interest, have been reviewed by external reviewers. The external reviewers, who have no potential conflicts of interest, have determined that no bias exists in these presentations. The external reviewers are:

Shannon L. DeVita, MSN, RN, CNL, DNP
Nurse Practioner
San Diego, California

Michele Nichols, PharmD
Pharmacy Consultant
Private Practice
Raritan, New Jersey
 top 

Accreditation Statements

Continuing Nursing Education with Distinction & Credit Designation
Letters & Sciences is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Each activity has been designated for 0.5 contact hours.

Nonendorsement of Products
The participant is advised that the educational content contained herein was developed by and reflects the opinions of the presenters and faculty, and does not necessarily reflect the opinions or recommendations of the educational provider or the commercial supporter. Accredited status does not imply endorsement by Letters & Sciences or the American Nurses Credentialing Center’s Commission on Accreditation of any commercial product discussed/displayed in conjunction with the educational activity.

 top 

Commercial Support

This program is supported by an educational grant from EMD Serono. EMD Serono Inc. is an affiliate of Merck KGaA, Darmstadt, Germany.

 top